|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
E-mail contact: obrosoig{at}pbrc.edu
Nitrosative stress, that is, enhanced peroxynitrite formation, has been documented in both experimental and clinical diabetic neuropathy (DN), but its pathogenetic role remains unexplored. This study evaluated the role for nitrosative stress in two animal models of type 1 diabetes: streptozotocin-diabetic mice and diabetic NOD mice. Control (C) and streptozotocin-diabetic (D) mice were treated with and without the potent peroxynitrite decomposition catalyst FP15 (5 mg kg–1 d–1) for 1 wk after 8 wk without treatment. Sciatic nerve nitrotyrosine (a marker of peroxynitrite-induced injury) and poly(ADP-ribose) immunoreactivities were present in D and absent in C and D+FP15. FP15 treatment corrected sciatic motor and hind-limb digital sensory nerve conduction deficits and sciatic nerve energy state in D, without affecting those variables in C. Nerve glucose and sorbitol pathway intermediate concentrations were similarly elevated in D and D+FP15 vs C. In diabetic NOD mice, a 7-day treatment with either 1 or 3 mg kg–1 d–1 FP15 reversed increased tail-flick latency (a sign of reduced pain sensitivity); the effect of the higher dose was significant as early as 3 days after beginning of the treatment. In conclusion, nitrosative stress plays a major role in DN in, at least, type 1 diabetes. This provides the rationale for development of agents counteracting peroxynitrite formation and promoting peroxynitrite decomposition, and their evaluation in DN.
Key words: poly(ADP-ribose) polymerase • streptozotocin-diabetic rats • NOD mice • nerve conduction deficit • tail-flick latency
This article has been cited by other articles:
![]() |
A. Masood, M. Yi, M. Lau, R. Belcastro, S. Shek, J. Pan, C. Kantores, P. J. McNamara, B. P. Kavanagh, J. Belik, et al. Therapeutic effects of hypercapnia on chronic lung injury and vascular remodeling in neonatal rats Am J Physiol Lung Cell Mol Physiol, November 1, 2009; 297(5): L920 - L930. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher and C. Szabo Role of the Peroxynitrite-Poly(ADP-Ribose) Polymerase Pathway in Human Disease Am. J. Pathol., July 1, 2008; 173(1): 2 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Ali, S. Matragoon, B. A. Pillai, G. I. Liou, and A. B. El-Remessy Peroxynitrite Mediates Retinal Neurodegeneration by Inhibiting Nerve Growth Factor Survival Signaling in Experimental and Human Diabetes Diabetes, April 1, 2008; 57(4): 889 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Toth, L. L. Rong, C. Yang, J. Martinez, F. Song, N. Ramji, V. Brussee, W. Liu, J. Durand, M. D. Nguyen, et al. Receptor for Advanced Glycation End Products (RAGEs) and Experimental Diabetic Neuropathy Diabetes, April 1, 2008; 57(4): 1002 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. G. Obrosova, V. R. Drel, C. L. Oltman, N. Mashtalir, J. Tibrewala, J. T. Groves, and M. A. Yorek Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1645 - E1655. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Maeng, M.-H. Kim, H.-E. Jin, S. M. Shin, T. Tsuruo, S. G. Kim, D.-D. Kim, C.-K. Shim, and S.-J. Chung Functional Induction of P-glycoprotein in the Blood-Brain Barrier of Streptozotocin-Induced Diabetic Rats: Evidence for the Involvement of Nuclear Factor-{kappa}B, a Nitrosative Stress-Sensitive Transcription Factor, in the Regulation Drug Metab. Dispos., November 1, 2007; 35(11): 1996 - 2005. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Poulsen, P. J. Moughan, and M. C. Kruger Long-Chain Polyunsaturated Fatty Acids and the Regulation of Bone Metabolism Exp Biol Med, November 1, 2007; 232(10): 1275 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. G. Obrosova, O. Ilnytska, V. V. Lyzogubov, I. A. Pavlov, N. Mashtalir, J. L. Nadler, and V. R. Drel High-Fat Diet Induced Neuropathy of Pre-Diabetes and Obesity: Effects of "Healthy" Diet and Aldose Reductase Inhibition Diabetes, October 1, 2007; 56(10): 2598 - 2608. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. R. Drel, N. Mashtalir, O. Ilnytska, J. Shin, F. Li, V. V. Lyzogubov, and I. G. Obrosova The Leptin-Deficient (ob/ob) Mouse: A New Animal Model of Peripheral Neuropathy of Type 2 Diabetes and Obesity Diabetes, December 1, 2006; 55(12): 3335 - 3343. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cuzzocrea, E. Mazzon, R. Di Paola, E. Esposito, H. Macarthur, G. M. Matuschak, and D. Salvemini A Role for Nitric Oxide-Mediated Peroxynitrite Formation in a Model of Endotoxin-Induced Shock J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 73 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tao, X. Jiao, E. Gao, W. B. Lau, Y. Yuan, B. Lopez, T. Christopher, S. P. RamachandraRao, W. Williams, G. Southan, et al. Nitrative Inactivation of Thioredoxin-1 and Its Role in Postischemic Myocardial Apoptosis Circulation, September 26, 2006; 114(13): 1395 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ilnytska, V. V. Lyzogubov, M. J. Stevens, V. R. Drel, N. Mashtalir, P. Pacher, M. A. Yorek, and I. G. Obrosova Poly(ADP-Ribose) Polymerase Inhibition Alleviates Experimental Diabetic Sensory Neuropathy Diabetes, June 1, 2006; 55(6): 1686 - 1694. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. G. Obrosova, V. R. Drel, P. Pacher, O. Ilnytska, Z. Q. Wang, M. J. Stevens, and M. A. Yorek Oxidative-Nitrosative Stress and Poly(ADP-Ribose) Polymerase (PARP) Activation in Experimental Diabetic Neuropathy: The Relation Is Revisited Diabetes, December 1, 2005; 54(12): 3435 - 3441. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Li, V. R. Drel, C. Szabo, M. J. Stevens, and I. G. Obrosova Low-Dose Poly(ADP-Ribose) Polymerase Inhibitor-Containing Combination Therapies Reverse Early Peripheral Diabetic Neuropathy Diabetes, May 1, 2005; 54(5): 1514 - 1522. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |